Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001114220-17-000024
Filing Date
2017-08-01
Accepted
2017-08-01 16:28:54
Documents
1
Period of Report
2017-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_150161932168614.html 4  
1 FORM 4 wf-form4_150161932168614.xml 4 3648
  Complete submission text file 0001114220-17-000024.txt   4955
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Adams Brian (Reporting) CIK: 0001636994 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 17997085